Stock Groups

Beyond Air Shares Continue Rally as Analysts Raise Price Targets -Breaking

by Mike Robinson

[ad_1]

© Reuters.

Sam Boughedda

Investing.com — Beyond Air Inc shares (NASDAQ:) continue Friday’s rally and are currently trading at 10% above their current levels.

Truist and Oppenheimer analyst raised stock price targets after last Thursday’s earnings from the medical device- and pharmaceutical company.

Truist cited FDA’s progress in reviewing LungFit PH’s product. Oppenheimer stated that the FDA was focusing its attention on PPHN’s launch. 

Gregory Fraser, a Truist analyst, raised Beyond Air’s price target to $16 (from $12), maintaining a buy rating. Suraj Kalia, an Oppenheimer analyst, raised Beyond Air’s stock price target to $13 ($9) and maintained an outperform rating

Roth Capital joined its peers Monday, as analyst Scott Henry raised the price target for Beyond Air shares from $11 to $15. He maintained a buy rating and said that it earned “fundamentally” as expected. 

Additionally, the analyst stated that investors are not paying enough attention to Beyond Air’s Nitric Ox Therapy. He believes that Beyond Air is the market leader in this technology. Henry explained to investors that Beyond Oncology’s spin-off is another factor in the price target changes.

 

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]